Brief: Fortress Biotech, Cyprium Therapeutics Announce $4.1 Mln Grant From NINDS
04/03/2024 15:08
March 4 (Reuters) - Fortress Biotech Inc FBIO.O :
* CYPRIUM THERAPEUTICS: $4.1 MILLION GRANT FROM NINDS TO
FURTHER
DEVELOPMENT OF AAV-ATP7A GENE THERAPY FOR MENKES DISEASE
Source text for Eikon: ID:nGNX5wCxhX
Further company coverage: FBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi